Practical Management of Cardiovascular Comorbidities in Rheumatoid Arthritis

Roberta Gualtierotti1, Nicola Ughi2, Giovanni Marfia3

  • 1Division of Rheumatology, ASST Pini, Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy. roberta.gualtierotti@unimi.it.

Insights

Rheumatoid arthritis (RA) patients frequently develop cardiovascular comorbidities like accelerated atherosclerosis. This review proposes a practical approach for cardiovascular risk assessment and management in RA, addressing gaps in current clinical guidelines.

Area of Science:

  • Rheumatology
  • Cardiology
  • Immunology

Background:

  • Cardiovascular (CV) comorbidities are common in rheumatoid arthritis (RA).
  • Accelerated atherosclerosis leading to cardiovascular disease (CVD) is a significant cause of mortality in RA patients.
  • Subclinical CVD can manifest early in RA, influenced by both traditional and non-traditional CV risk factors.

Purpose of the Study:

  • To propose a practical approach for CV risk assessment and management in RA patients.
  • To address the lack of clear guidelines for CV risk stratification and intervention in RA.
  • To synthesize available evidence for managing CVD in the context of RA.

Main Methods:

  • Review of available evidence on CV comorbidities in RA.
  • Analysis of traditional and non-traditional CV risk factors in RA pathogenesis.
  • Synthesis of current understanding of subclinical CVD in early RA.

Main Results:

  • Cardiovascular disease is a major concern in RA, linked to accelerated atherosclerosis.
  • Both traditional and non-traditional risk factors contribute to RA-related CVD.
  • Current evidence is insufficient for definitive CV risk assessment tools and interventions in RA.

Conclusions:

  • A practical approach is proposed for CV risk assessment and management in RA.
  • Further research, including randomized clinical trials, is needed to refine strategies.
  • Early identification and management of subclinical CVD are crucial in RA patients.

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
419
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
370
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
482
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
625
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
768
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
432